Plant Comparison
Chaga vs Holy Basil
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
First plant
Second plant
Show:
At a glance
Chaga and Holy Basil: they share 7 indicated uses (arthritis / joint pain, cancer (anticancer research), cold & flu, …); 5 pharmacological actions in common.
ChagaHoly Basil
Constituents32
Pharmacological actions106
Indicated uses1112
Safety notes22
Cited sources4116
Indicated uses
Only Chaga
Infection (general)Metabolic supportWoundsCardiovascular / heart health
Shared (7)
Arthritis / joint painCancer (anticancer research)Cold & fluImmune supportInflammation (general)Skin irritationCognitive function
Only Holy Basil
AnxietyBlood sugar / diabetes supportFatigue / low energyMemoryStress
Pharmacological actions
Only Chaga
AntimicrobialNephroprotective (kidney support)Antidiabetic (blood-sugar lowering)Hepatoprotective (liver support)Lipid-lowering
Shared (5)
Anti-inflammatoryAnticancer (preclinical)AntioxidantImmunomodulator / immune supportNeuroprotective / cognition support
Only Holy Basil
Adaptogen
Evidence face-off — shared uses
| Condition | Chaga | Holy Basil | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 8/10 | Stronger for Holy Basil |
| Cold & flu | 1/10 | 7/10 | Stronger for Holy Basil |
| Immune support | 2/10 | 7/10 | Stronger for Holy Basil |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Cognitive function | 2/10 | 5/10 | Stronger for Holy Basil |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Melanin-rich pigments and betulinic acid derivatives[1]
Chaga's dark colour comes from melanin-like pigments; it also concentrates betulinic-acid-type triterpenes absorbed from its birch host, associated with antioxidant and anticancer research interest.
Polysaccharides (beta-glucans)[4]
Immunomodulatory polysaccharides contributing to the traditional tonic and immune-support use.
Polysaccharides
Phenolic compounds[4]
Antioxidant phenolics contributing to chaga's free-radical-scavenging activity.
Phenolic compounds
Pharmacological Actions
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
Neuroprotective / cognition support[14]
Cognitive support - a placebo-controlled study in healthy adults found improved reaction time and accuracy and shorter P300 latency
Traditional & Indicated Uses
inferred from anti-inflammatory action
Evidence: 1
Label: Arthritis / joint pain
inferred from anticancer action
Evidence: 2
Label: Cancer (anticancer research)
inferred from immunomodulator action
Evidence: 1
Label: Cold & flu
inferred from antimicrobial action
Evidence: 1
Label: Infection (general)
inferred from anti-inflammatory action
Evidence: 1
Label: Inflammation (general)
inferred from anti-inflammatory action
Evidence: 1
Label: Skin irritation
Chaga-derived 3,4-DHBA protected against Parkinson's-related neurotoxicity (preclinical).
Evidence: 2
Label: Cognitive function
Cardiovascular / heart health[33]Traditional · 2/10
Chaga polysaccharide lowered lipids in vivo and in vitro.
Evidence: 2
Label: Cardiovascular / heart health
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
Evidence: 8
Label: Anxiety
Arthritis / joint pain[11]Traditional · 1/10
inferred from anti-inflammatory action
Evidence: 1
Label: Arthritis / joint pain
Supports blood-sugar control (lowers fasting and post-meal glucose)
Evidence: 7
Label: Blood sugar / diabetes support
inferred from anticancer action
Evidence: 8
Label: Cancer (anticancer research)
Cognitive function[14]Moderate · 5/10
inferred from neuroprotective action
Evidence: 5
Label: Cognitive function
Fatigue / low energy[12]Good · 7/10
inferred from adaptogen action
Evidence: 7
Label: Fatigue / low energy
Inflammation (general)[11]Traditional · 1/10
inferred from anti-inflammatory action
Evidence: 1
Label: Inflammation (general)
Skin irritation[11]Traditional · 1/10
inferred from anti-inflammatory action
Evidence: 1
Label: Skin irritation
Safety, Cautions & Contraindications
Autoimmune conditions: Chaga can stimulate parts of the immune system—people with autoimmune diseases should be cautious.Blood thinners: Chaga contains compounds that may affect clotting—avoid large doses if on anticoagulants.Blood sugar meds: May slightly lower glucose—monitor if taking diabetes medication.Pregnancy & breastfeeding: Limited safety data—best avoided unless guided by a professional.Quality matters: Wild-harvested Chaga can accumulate heavy metals from trees and soil—source from reputable suppliers.
Safety note[12]Caution
Generally well tolerated; mild nausea has been reported. Its blood-sugar-lowering effect means caution alongside antidiabetic medicines.
External Ids
Gbif: 2521089
Wikidata: Q1956937
Gbif: 2927100
Wikidata: Q960124
Botanical Description
Parasitic wood-decay fungus (not a true plant) that grows almost entirely inside the trunk of living birch trees, visible externally only as a hard, black, cracked, charcoal-like mass (a sclerotium, sometimes called a 'conk') erupting through the bark. Unlike typical mushrooms, chaga has no true cap, gills or stem; its fertile spore-producing surface develops later, hidden beneath the bark after the tree dies.[1]
Height: External mass 10-40 cm
Habit: Parasitic wood-decay fungus, growing mostly inside the host tree
Leaves: Not applicable (fungus)
Flowers: Not applicable (fungus); reproduces by spores
Stem: No true cap-and-stem structure; visible only as a hard black external mass (sclerotium)
Root: Fungal mycelium spreading through the living wood of the host tree
Fruit: Fertile spore-producing layer develops hidden beneath the bark, typically after the host tree dies
Flowering Period: The visible black mass persists and grows for years; not a seasonal fruiting body
Aromatic annual or short-lived perennial subshrub (Lamiaceae), 30-75 cm tall, with erect, much-branched, hairy stems often tinged purple. Leaves are opposite, ovate-oblong with a toothed margin, and release a strong, clove-like (eugenol) scent when crushed. Small purplish-pink, two-lipped flowers are borne in elongated terminal racemes. The plant is held sacred in Hindu tradition (Tulsi).[11]
Height: 30-75 cm
Habit: Erect, much-branched, aromatic subshrub
Leaves: Opposite, ovate-oblong, toothed, clove-scented when crushed
Flowers: Small, purplish-pink, two-lipped, in elongated terminal racemes
Stem: Erect, much-branched, hairy, often purple-tinged
Root: Fibrous root system
Fruit: Four small nutlets (typical Lamiaceae schizocarp)
Flowering Period: Most of the year in tropical climates
Habitat
Grows almost exclusively as a parasite on living birch trees in cold, northern temperate and boreal forests of Europe, Russia, North America and Asia.[1]
Native to the Indian subcontinent and tropical Asia, now cultivated and naturalised throughout the tropics and subtropics worldwide; commonly grown in home gardens and temple courtyards as well as cultivated as a medicinal and aromatic crop.[12]
Harvesting
The hard black external mass (conk) is chopped or broken away from the living birch trunk, ideally without killing the tree, then dried and broken into pieces or ground for use; sustainable harvesting (leaving part of the conk to regrow) is recommended given the fungus's slow growth.
Parts: Mycelium, Whole Plant
Leaves are harvested year-round from actively growing plants, ideally picked once morning dew has dried; whole flowering tops are also gathered.
Parts: Leaf, Flowering tops
Season: Year-round in warm climates
Traditional Uses
Chaga has a long traditional use in Russian, Siberian, Baltic and Scandinavian folk medicine as a tonic remedy for digestive complaints, immune support and general vitality, traditionally taken as a dark, tea-like decoction; this traditional tonic reputation is now studied for its antioxidant, immunomodulatory and anti-inflammatory properties.[1, 4]
Tulsi is one of the most revered plants in Ayurvedic medicine, traditionally used as an adaptogen for stress, a remedy for respiratory complaints (colds, cough, asthma), and a general immune tonic. Modern clinical trials support adaptogenic/anti-stress, blood-sugar-lowering and immunomodulatory effects consistent with these traditional uses.[3, 12]
Preparations
References
REF-0848, REF-0849, REF-0850, REF-2195, REF-2196, REF-2197, REF-2198, REF-2199, REF-2200, REF-2201, REF-2202, REF-2203, REF-2204, REF-2969, REF-2970, REF-2971, REF-2972, REF-2973, REF-2974, REF-2975, REF-2976, REF-2977, REF-2978, REF-2979, REF-2980, REF-2981, REF-2982, REF-2983, REF-2984, REF-2985, REF-2986, REF-2987, REF-2988, REF-2989, REF-2990, REF-2991, REF-2992
REF-1427, REF-1428, REF-1429, REF-1430, REF-1431, REF-1432, REF-1433, REF-1434, REF-1435, REF-1436
Lookalikes Review
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Dosage
Not documented
Clinical trials for stress and mood have used standardised dry-extract capsules taken over several weeks; dosing varies by product concentration, so follow the manufacturer's guidance. Educational reference only, not a prescription.
Infusion (tea)[13]
The WHO monograph on Folium Ocimi Sancti gives a daily dosage of 6-12 g of the crude drug as a decoction. This is a whole-day total for the fresh or dried leaf, notably higher than the 1-2 g per cup often quoted in popular sources. Educational reference only, not a prescription.
Drug Class Interactions
Not documented
Drug Class: antidiabetics
Mechanism: Holy basil (tulsi) can lower fasting and after-meal blood glucose in people with type 2 diabetes; combined with diabetes medicines it may add to blood-sugar lowering, so monitor blood sugar.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
References & Sources
- Camilleri, E., Blundell, R., Baral, B., Karpinski, T.M. et al (2024) 'A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms', Heliyon, 10(15), pp. e35638. doi:10.1016/j.heliyon.2024.e35638 Traditional / reference
https://doi.org/10.1016/j.heliyon.2024.e35638 - Lu, Y., Jia, Y., Xue, Z., Li, N. et al (2021) 'Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application', Polymers (Basel), 13(9), pp. 1441. doi:10.3390/polym13091441 Traditional / reference
https://doi.org/10.3390/polym13091441 - Kobus, Z., Krzywicka, M., Blicharz-Kania, A., Bosacka, A. et al (2024) 'Impact of Incorporating Dried Chaga Mushroom (Inonotus obliquus) into Gluten-Free Bread on Its Antioxidant and Sensory Characteristics', Molecules, 29(16), pp. 3801. doi:10.3390/molecules29163801 Preclinical
https://doi.org/10.3390/molecules29163801 - Szychowski, K.A., Skora, B., Pomianek, T. and Gminski, J (2020) 'Inonotus obliquus - from folk medicine to clinical use', Journal of Traditional and Complementary Medicine, 11(4), pp. 293-302. doi:10.1016/j.jtcme.2020.08.003 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2020.08.003 - Javed, S., Mitchell, K., Sidsworth, D., Sellers, S.L., Reutens-Hernandez, J., Massicotte, H.B., Egger, K.N., Lee, C.H. and Payne, G.W (2019) 'Inonotus obliquus attenuates histamine-induced microvascular inflammation', PLoS One, 14(8), pp. e0220776. doi:10.1371/journal.pone.0220776 Preclinical
https://doi.org/10.1371/journal.pone.0220776 - Zou, C., Hou, Z., Bai, M., Guo, R., Lin, B., Wang, X., Huang, X. and Song, S (2020) 'Highly modified steroids from Inonotus obliquus', Organic & Biomolecular Chemistry, 18(20), pp. 3908-3916. doi:10.1039/d0ob00474j Preclinical
https://doi.org/10.1039/d0ob00474j - Zhong, X.H., Ren, K., Lu, S.J., Yang, S.Y. and Sun, D.Z (2009) 'Progress of research on Inonotus obliquus', Chinese Journal of Integrative Medicine, 15(2), pp. 156-160. doi:10.1007/s11655-009-0156-2 Meta-analysis / review
https://doi.org/10.1007/s11655-009-0156-2 - Burmasova, M.A., Utebaeva, A.A., Sysoeva, E.V. and Sysoeva, M.A (2019) 'Melanins of Inonotus obliquus: bifidogenic and antioxidant properties', Biomolecules, 9(6), pp. 248. doi:10.3390/biom9060248 Preclinical
https://doi.org/10.3390/biom9060248 - Sun, Y., Deng, X., Li, Z., Dong, Y., Jiang, W., Ma, Y., Zhou, W., Zhu, T., Wang, G., Liu, S. and Hu, B (2022) 'Polysaccharide derived from Inonotus obliquus inhibits lipopolysaccharide-induced acute endometritis in mice', American Journal of Translational Research, 14(11), pp. 8332-8342. Preclinical
https://scholar.google.com/scholar?q=Polysaccharide%20derived%20from%20Inonotus%20obliquus%20inhibits%20lipopolysaccharide-induced%20acute%20endometritis%20in%20mice - Ishfaq, P.M., Mishra, S., Mishra, A., Ahmad, Z., Gayen, S., Jain, S.K., Tripathi, S. and Mishra, S.K (2022) 'Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin', Current Research in Pharmacology and Drug Discovery, 3, pp. 100118. doi:10.1016/j.crphar.2022.100118 Preclinical
https://doi.org/10.1016/j.crphar.2022.100118 - Peng, A., Liu, S., Fang, L., Zhu, Z., Zhou, Y., Yue, S., Ma, Z., Liu, X., Xue, S., Qiu, Y. and Qi, R (2022) 'Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis', European Journal of Pharmacology, 921, pp. 174841. doi:10.1016/j.ejphar.2022.174841 Preclinical
https://doi.org/10.1016/j.ejphar.2022.174841 - Zhang, Y., Liu, Q., Sun, Y. and Jiang, J (2023) 'Inonotus obliquus sclerotia epidermis were different from internal tissues in compound composition, antioxidant activity, and associated fungi', FEMS Microbiology Letters, 370, pp. fnad126. doi:10.1093/femsle/fnad126 Preclinical
https://doi.org/10.1093/femsle/fnad126 - Yu, S., Lai, Z., Xue, H., Zhu, J., Yue, G., Wang, J. and Jin, L.H (2024) 'Inonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila', Toxicology Mechanisms and Methods, 34(9), pp. 970-984. doi:10.1080/15376516.2024.2368795 Preclinical
https://doi.org/10.1080/15376516.2024.2368795 - Wold, C.W. and Christopoulos, P. and Arias, M. and Dzovor, D.E. and Øynebråten, I. and Corthay, A. and Inngjerdingen, K.T (2024) 'Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity', Communications Biology. doi:10.1038/s42003-024-05853-y Preclinical
https://doi.org/10.1038/s42003-024-05853-y - Li, J. and Qu, C. and Li, F. and Chen, Y. and Zheng, J. and Xiao, Y. and Jin, Q. and Jin, G. and Huang, X. and Jin, D (2021) 'Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome', Frontiers in Pharmacology. doi:10.3389/fphar.2020.621835 Preclinical
https://doi.org/10.3389/fphar.2020.621835 - Wold, C.W. and Gerwick, W.H. and Wangensteen, H. and Inngjerdingen, K.T (2020) 'Bioactive triterpenoids and water-soluble melanin from Inonotus obliquus (Chaga) with immunomodulatory activity', Journal of Functional Foods. doi:10.1016/j.jff.2020.104025 Preclinical
https://doi.org/10.1016/j.jff.2020.104025 - Kim, J. and Yang, S. and Hwang, A.Y. and Cho, H. and Hwang, K.T (2020) 'Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines', Molecules. doi:10.3390/molecules25184066 Preclinical
https://doi.org/10.3390/molecules25184066 - Duru, K.C. and Kovaleva, E.G. and Данилова, И.Г. and Bijl, P.V.D (2019) 'The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies', Phytotherapy Research. doi:10.1002/ptr.6384 Preclinical
https://doi.org/10.1002/ptr.6384 - Hu, Y. and Teng, C. and Yu, S. and Wang, X. and Liang, J. and Bai, X. and Dong, L. and Song, T. and Yu, M. and Qu, J (2017) 'Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice', AMB Express. doi:10.1186/s13568-017-0341-1 Preclinical
https://doi.org/10.1186/s13568-017-0341-1 - Chou, Y. and Kan, W. and Chang, C. and Peng, Y. and Wang, H. and Yu, W. and Cheng, Y. and Jhang, Y. and Liu, H. and Chuu, J (2016) 'Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice', International Journal of Molecular Sciences. doi:10.3390/ijms17091535 Preclinical
https://doi.org/10.3390/ijms17091535 - Arata, S. and Watanabe, J. and Maeda, M. and Yamamoto, M. and Matsuhashi, H. and Mochizuki, M. and Kagami, N. and Honda, K. and Inagaki, M (2016) 'Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice', Heliyon. doi:10.1016/j.heliyon.2016.e00111 Preclinical
https://doi.org/10.1016/j.heliyon.2016.e00111 - Lee, K.R. and Lee, J.S. and Kim, Y.R. and Song, I.G. and Hong, E.K (2014) 'Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway', Oncology Reports. doi:10.3892/or.2014.3103 Preclinical
https://doi.org/10.3892/or.2014.3103 - Song, F. and Liu, Y. and Kong, X. and Chang, W. and Song, G (2013) 'Progress on Understanding the Anticancer Mechanisms of Medicinal Mushroom: Inonotus Obliquus', Asian Pacific Journal of Cancer Prevention. doi:10.7314/apjcp.2013.14.3.1571 Preclinical
https://doi.org/10.7314/apjcp.2013.14.3.1571 - Gunjima, K. and Tomiyama, R. and Takakura, K. and Yamada, T. and Hashida, K. and Nakamura, Y. and Konishi, T. and Matsugo, S. and Hori, O (2013) '3,4‐Dihydroxybenzalacetone Protects Against Parkinson's Disease‐Related Neurotoxin 6‐OHDA Through Akt/Nrf2/Glutathione Pathway', Journal of Cellular Biochemistry. doi:10.1002/jcb.24643 Preclinical
https://doi.org/10.1002/jcb.24643 - Geng, Y. and Lu, Z. and Huang, W. and Xu, H. and Shi, J. and Xu, Z (2013) 'Bioassay-Guided Isolation of DPP-4 Inhibitory Fractions from Extracts of Submerged Cultured of Inonotus obliquus', Molecules. doi:10.3390/molecules18011150 Preclinical
https://doi.org/10.3390/molecules18011150 - Zhang, L. and Fan, C. and Liu, S. and Zang, Z. and Jiao, L. and Zhang, L (2011) 'Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus', Journal of Medicinal Plants Research. doi:10.5897/jmpr.9000346 Preclinical
https://doi.org/10.5897/jmpr.9000346 - Choi, S. and Hur, S.J. and An, C.S. and Jeon, Y.H. and Jeoung, Y.J. and Bak, J.P. and Lim, B.O (2010) 'Anti-Inflammatory Effects ofInonotus obliquusin Colitis Induced by Dextran Sodium Sulfate', Journal of Biomedicine and Biotechnology. doi:10.1155/2010/943516 Preclinical
https://doi.org/10.1155/2010/943516 - Youn, M. and Kim, J. and Park, S. and Kim, Y. and Kim, S. and Lee, J.S. and Chai, K.Y. and Kim, H. and Cui, M. and So, H.S. and Kim, K. and Park, R (2008) 'Chaga mushroom (Inonotus obliquus ) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells', World Journal of Gastroenterology. doi:10.3748/wjg.14.511 Preclinical
https://doi.org/10.3748/wjg.14.511 - Nakajima, Y. and Sato, Y. and Konishi, T (2007) 'Antioxidant Small Phenolic Ingredients in Inonotus obliquus (persoon) Pilat (Chaga)', Chemical and Pharmaceutical Bulletin. doi:10.1248/cpb.55.1222 Preclinical
https://doi.org/10.1248/cpb.55.1222 - Kim, H. and Yoon, D. and Kim, C. and Shrestha, B. and Chang, W. and Lim, S. and Lee, W. and Han, S. and Lee, J. and Lim, M. and Kim, G. and Choi, S. and Song, W.O. and Sung, J. and Hwang, K (2007) 'Ethanol Extract of Inonotus obliquus Inhibits Lipopolysaccharide-Induced Inflammation in RAW 264.7 Macrophage Cells', Journal of Medicinal Food. doi:10.1089/jmf.2006.156 Preclinical
https://doi.org/10.1089/jmf.2006.156 - Mizuno, T. and Zhuang, C. and Abe, K. and Okamoto, H. and Kiho, T. and Ukai, S. and Leclerc, S. and Meijer, L (1999) 'Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)', International journal of medicinal mushrooms. doi:10.1615/intjmedmushr.v1.i4.20 Preclinical
https://doi.org/10.1615/intjmedmushr.v1.i4.20 - Su, L. and Xin, C. and Yang, J. and Dong, L. and Mei, H. and Dai, X. and Wang, Q (2022) 'A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2022.06.071 Preclinical
https://doi.org/10.1016/j.ijbiomac.2022.06.071 - Yang, M. and Hu, D. and Cui, Z. and Li, H. and Man, C. and Jiang, Y (2021) 'Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro', Foods. doi:10.3390/foods10123085 Preclinical
https://doi.org/10.3390/foods10123085 - Wang, J. and Hu, W. and Li, L. and Huang, X. and Liu, Y. and Wang, D. and Teng, L (2017) 'Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes', PLoS ONE. doi:10.1371/journal.pone.0180476 Preclinical
https://doi.org/10.1371/journal.pone.0180476 - Giridharan, V.V. and Thandavarayan, R.A. and Konishi, T (2011) 'Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus– a medicinal mushroom', Food & Function. doi:10.1039/c1fo10037h Preclinical
https://doi.org/10.1039/c1fo10037h - Lee, J. and Hyun, C (2014) 'Insulin‐Sensitizing and Beneficial Lipid‐Metabolic Effects of the Water‐Soluble Melanin Complex Extracted from Inonotus obliquus', Phytotherapy Research. doi:10.1002/ptr.5131 Preclinical
https://doi.org/10.1002/ptr.5131 - Kim, Y (2005) 'Immunomodulatory Activity of the Water Extract from Medicinal MushroomInonotus obliquus', Mycobiology. doi:10.4489/myco.2005.33.3.158 Preclinical
https://doi.org/10.4489/myco.2005.33.3.158 - Géry, A., Dubreule, C., André, V., Rioult, J.P., Bouchart, V., Heutte, N., Eldin de Pécoulas, P., Krivomaz, T. and Garon, D (2018) 'Chaga (Inonotus obliquus), a future potential medicinal fungus in oncology? A chemical study and a comparison of the cytotoxicity against human lung adenocarcinoma cells (A549) and human bronchial epithelial cells (BEAS-2B)', 17(3), pp. 832--843. doi:10.1177/1534735418757912 Traditional / reference
https://doi.org/10.1177/1534735418757912 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Shashkina, M.Ya., Shashkin, P.N. and Sergeev, A.V (2006) 'Chemical and medicobiological properties of chaga', 40(10), pp. 560--568. Traditional / reference
https://scholar.google.com/scholar?q=Chemical%20and%20medicobiological%20properties%20of%20chaga - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Lopresti, A.L., Smith, S.J., Metse, A.P. and Drummond, P.D (2022) 'A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress', Frontiers in Nutrition, 9, pp. 965130. doi:10.3389/fnut.2022.965130 Randomized trial
https://doi.org/10.3389/fnut.2022.965130 - Baliga, M.S., Jimmy, R., Thilakchand, K.R., Sunitha, V. and others (2013) 'Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer', Nutrition and Cancer, 65(Suppl 1), pp. 26-35. doi:10.1080/01635581.2013.785010 Meta-analysis / review
https://doi.org/10.1080/01635581.2013.785010 - Cohen, M.M (2014) 'Tulsi - Ocimum sanctum: A herb for all reasons', Journal of Ayurveda and Integrative Medicine, 5(4), pp. 251-259. doi:10.4103/0975-9476.146554 Meta-analysis / review
https://doi.org/10.4103/0975-9476.146554 - Arya, R., Faruquee, H.M., Shakya, H., Rahman, S.A. and others (2024) 'Harnessing the Antibacterial, Anti-Diabetic and Anti-Carcinogenic Properties of Ocimum tenuiflorum Linn (Tulsi)', Plants, 13(24), pp. 3516. doi:10.3390/plants13243516 Preclinical
https://doi.org/10.3390/plants13243516 - Prakash, P. and Gupta, N (2005) 'Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review', Indian Journal of Physiology and Pharmacology, 49(2), pp. 125-131. Meta-analysis / review
https://scholar.google.com/scholar?q=Therapeutic%20uses%20of%20Ocimum%20sanctum%20Linn%20%28Tulsi%29%20with%20a%20note%20on%20eugenol%20and%20its%20pharmacological%20actions%3A%20a%20short%20review - Jayapal, V., Vidya Raj, C.K., Muthaiah, M., Chadha, V.K. and others (2021) 'In-vitro anti-Mycobacterium tuberculosis effect of essential oil of Ocimum sanctum L. (Tulsi/Basil) leaves', Indian Journal of Tuberculosis, 68(4), pp. 470-473. doi:10.1016/j.ijtb.2021.02.009 Preclinical
https://doi.org/10.1016/j.ijtb.2021.02.009 - Baliga, M.S., Rao, S., Rai, M.P. and D'souza, P (2016) 'Radio protective effects of the Ayurvedic medicinal plant Ocimum sanctum Linn. (Holy Basil): A memoir', Journal of Cancer Research and Therapeutics, 12(1), pp. 20-27. doi:10.4103/0973-1482.151422 Meta-analysis / review
https://doi.org/10.4103/0973-1482.151422 - Kamel, F.O., Karim, S., Bafail, D.A.O., Aldawsari, H.M. and others (2023) 'Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats', Frontiers in Pharmacology, 14, pp. 1213052. doi:10.3389/fphar.2023.1213052 Preclinical
https://doi.org/10.3389/fphar.2023.1213052 - Yadav, I., Kumar, R., Fatima, Z. and Rema, V (2024) 'Ocimum sanctum (Tulsi) as a Potential Immunomodulator for the Treatment of Ischemic Injury in the Brain', Current Molecular Medicine, 24(1), pp. 60-73. doi:10.2174/1566524023666221212155340 Meta-analysis / review
https://doi.org/10.2174/1566524023666221212155340 - Kumar, P. and Patel, D (2023) 'Ocimum Sanctum: An All-Round Treatment for Cancer?', Alternative Therapies in Health and Medicine, 29(4), pp. 253-257. Meta-analysis / review
https://scholar.google.com/scholar?q=Ocimum%20Sanctum%3A%20An%20All-Round%20Treatment%20for%20Cancer%3F - Bhattacharyya, P. and Bishayee, A (2013) 'Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancer', Anti-Cancer Drugs. doi:10.1097/CAD.0b013e328361aca1 Traditional / reference
https://doi.org/10.1097/CAD.0b013e328361aca1 - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - World Health Organization (2002) 'Folium Ocimi Sancti'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sampath, S., Mahapatra, S.C., Padhi, M.M., Sharma, R. and Talwar, A (2015) 'Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study', Indian Journal of Physiology and Pharmacology, 59(1), pp. 69--77. Randomized trial
https://scholar.google.com/scholar?q=Holy%20basil%20%28Ocimum%20sanctum%20Linn.%29%20leaf%20extract%20enhances%20specific%20cognitive%20parameters%20in%20healthy%20adult%20volunteers%3A%20A%20placebo%20controlled%20study - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine, 2017, pp. 9217567. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - Agrawal, P., Rai, V. and Singh, R.B (1996) 'Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus', International Journal of Clinical Pharmacology and Therapeutics, 34(9), pp. 406-409. Randomized trial
https://scholar.google.com/scholar?q=Randomized%20placebo-controlled%2C%20single%20blind%20trial%20of%20holy%20basil%20leaves%20in%20patients%20with%20noninsulin-dependent%20diabetes%20mellitus
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.